J. Scott Roberts, Ph.D.
Associate Professor, Health Behavior & Health Education
Director, Certificate in Public Health Genetics Program
Co-Director, Dual-Degree (MPH/MS) Program in Public Health and Genetic Counseling
Director, Genomics, Health & Society Program, Center for Bioethics and Social Sciences in Medicine
(734) 936-9854; Fax: (734) 763-7379
Curriculum Vitae (PDF)
- Professional Summary
- Courses Taught
- Research Interest & Projects
- Selected Publications
- Professional Affiliations
- Additional Information
- Recent News Items
Dr. Roberts is Associate Professor in the Department of Health Behavior & Health Education (HBHE) and Director of the SPH Public Health Genetics Certificate program. Prior to joining the HBHE faculty in Fall 2006, he was Assistant Professor in the Department of Neurology at Boston University (BU) School of Medicine, where he was Co-Director of the Education Core in the NIH-funded BU Alzheimer's Disease Center. At U-M, he serves as a Co-Director of the U-M dual-degree program in Public Health and Genetic Counseling and leads the Genomics, Health & Society program within the U-M Center for Bioethics & Social Sciences in Medicine. He also directs the Outreach, Recruitment and Education Core of the Michigan Alzheimer's Disease Center.
Ph.D., Clinical Psychology, University of Michigan, 1999
M.A., Clinical Psychology, University of Michigan, 1996
B.A., English, Duke University, 1992
Research Interests & Projects
Dr. Roberts' research interests focus on the process and impact of genetic risk assessment for adult-onset disorders. He has served since 2001 as Co-Principal Investigator of the REVEAL Study (Risk Evaluation & Education for Alzheimer's Disease), an NIH-funded series of clinical trials assessing the psychological and behavioral impact of genetic risk disclosure for Alzheimer's disease (AD). Now having recently completed its fourth trial, the REVEAL Study has examined the effects of APOE genotype-based risk disclosure to individuals at elevated risk for AD. In addition, Dr. Roberts is joint PI of a NIH-funded project to examine the motivations, attitudes and behaviors of consumers receiving personal genomics services. Finally, Dr. Roberts collaborates with investigators at the U-M Comprehensive Cancer Center on a project to examine ethical and health communication issues involved in the use of whole-genome sequencing to customize care of patients with advanced and refractory cancers. This project is part of the national NIH Clinical Sequencing Exploratory Research (CSER) consortium.
Roberts, J. S., Dolinoy, D. C. & Tarini, B. A. (2014). Emerging issues in public health genomics. Annual Review of Genomics and Human Genetics, 15.
Roberts, J. S., Connell, C. M., & McLaughlin, S. (2014). Public knowledge and beliefs about risk and protective factors for Alzheimer's disease: Findings from the Health and Retirement Study. Alzheimer's and Dementia.
Roberts J.S., Dunn L., & Rabinovici, G. (2013). Amyloid imaging, risk disclosure, and Alzheimer’s disease: Ethical and practical issues. Neurodegenerative Disease Management, 3(3), 219-29.
Roberts J.S., & Uhlmann W.R. (2013). Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues. Progress in Neurobiology, 110, 89-101.
Roberts J.S., Chen C., Uhlmann W., & Green R.C. (2012). Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer's disease: The REVEAL Study. Genetics In Medicine, 14, 742-48.
Roberts JS, Christensen KD, Green RC (2011). Using Alzheimer's disease as a model for genetic risk disclosure: Implications for personal genomics Clinical Genetics, 80, 407-414.
Roberts, J.S., Shalowitz, D.I., Christensen, K.D., Everett, J., Kim, S., Raskin, L., Gruber, S.B. (2010). Returning individual research results: Development of a cancer genetics education and risk communication protocol. Journal of Empirical Research on Human Research Ethics., 5, 17-30.
Roberts, J.S., Karlawish, J., Uhlmann, W., Petersen, R., Green, R.C. (2010). Mild cognitive impairment in clinical care: A survey of neurologists' attitudes and practices. Neurology, 75, 425-31.
Roberts, J.S., Tersegno, S. (2010). Estimating and disclosing the risk of developing Alzheimer's disease: Challenges, controversies and future directions. Future Neurology, 5, 501-517.
Green, R.C., Roberts, J.S., et al. (2009). A randomized trial of APOE disclosure for risk of Alzheimer's disease: The REVEAL Study. New England Journal of Medicine, 361, 245-254.
- American Public Health Association
- American Society of Bioethics and the Humanities
- International Society to Advance Alzheimer's Research & Treatment
Rabid Duke basketball fan
REVEAL Study participants talk about their genetic test results
Exemplary Teaching: Using CTools to Enhance Interactive Teaching
Recent News Items
- "New Methods Reported For Safely And Accurately Disclosing Alzheimer's Disease Risk Based On Newly Approved Tests," Market Watch- The Wall Street Journal, July 17, 2012
- "Study on the personal impact of consumer genomics services," PHG Foundation, March 06, 2012
- "It’s Mild Cognitive Impairment. Now What?," The New York Times Health, November 23, 2011
- "Alzheimer's Disease Risk Study for those with Mild Cognitive Impairment," 1320 WILS Radio, November 18, 2011
- "Alzheimer's risk: Would you want to know?," University of Michigan News Service, July 16, 2009
- "Dementia diagnosis may relieve patients," Associated Press, March 13, 2008